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Abstract: Pokemon is an important proto-oncogene that plays a critical role in cellular 
oncogenic transformation and tumorigenesis. Anoikis, which is regulated by Bim-mediated 
apoptosis, is critical to cancer cell invasion and metastasis. We investigated the role of 
Pokemon in anoikis, and our results show that Pokemon renders liver cells resistant to 
anoikis  via  suppression  of  Bim  transcription.  We  knocked-down  Pokemon  in  human 
hepatoma cells QGY7703 with small interfering RNAs (siRNA). Knockdown of Pokemon 
alone did not significantly affect the growth and survival of QGY7703 cells but notably 
enhanced their sensitivity to apoptotic stress due to the presence of chemical agents or cell 
detachment,  thereby  inducing  anoikis,  as  evidenced  by  flow  cytometry  and  caspase-3 
activity  assays.  In  contrast,  ectopic  expression  of  Pokemon  in  HL7702  cells  led  to 
resistance to anoikis. Dual-luciferase reporter and ChIP assays illustrated that Pokemon 
suppressed Bim transcription via direct binding to its promoter. Our results suggest that 
Pokemon prevents anoikis through the suppression of Bim expression, which facilitates 
tumor cell invasion and metastasis. This Pokemon-Bim pathway may be an effective target 
for therapeutic intervention for cancer. 
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1. Introduction 
Pokemon, an erythroid myeloid ontogenic factor, is a member of the POK (POZ and Krü ppel) 
family of transcriptional repressors [1]. Pokemon is a master regulator of B-cell and T-cell lymphoid 
fate and erythroid development and maturation [2,3]. However, aberrant over-expression of Pokemon 
in some human tumors, such as breast and liver cancer, lymphomas and adult malignant glioma [4–6], 
plays a key role in oncogenic transformation and tumorigenesis. Pokemon acts as a proto-oncogene by 
inhibiting  the  expression  of  several  important  tumor  suppressors.  For  instance,  Pokemon  prevents 
apoptosis  via  suppression  of  p53  and  Bim  to  promote  cell  survival  with  a  tendency  towards 
transformation. Pokemon suppresses p53 via the ARF-MDM2-p53 pathway but down-regulates Bim 
via direct binding to its promoter [7,8]. Pokemon also represses p21 and Rb expression to promote cell 
cycle  progression.  p21  is  an  inhibitor  of  cyclin-cdk2  complexes  and  a  major  regulator  of  the 
mammalian cell cycle [9–11], whereas Rb controls cell cycle progression at the G1/S checkpoint by 
suppressing the activity of an important transcription factor [12–14]. In addition, Pokemon promotes 
fatty acid synthesis to generate the membrane components phospholipids, which needed for rapid cell 
growth and proliferation [15,16]. Therefore, Pokemon has many functions in cancer cells that promote 
cell  survival  and  cell  cycle  progression.  These  functions  may  also  be  essential  for  embryonic 
development. For example, the abrogation of Pokemon expression leads to lethal anemia in mouse 
embryos  due  to  apoptosis  of  late-stage  erythroblasts.  This  programmed  cell  death  is  mediated  by 
upregulation  of  the  pro-apoptotic  factor,  Bim,  in  Pokemon-null  cells.  GATA1  suppresses  
Bim-mediated apoptosis [3,17]. 
The Bcl-2 family of proteins is composed of both pro-apoptotic and anti-apoptotic members. The 
BH3-only protein Bim is pro-apoptotic, as it both activates Bax and suppresses the anti-apoptotic Bcl-2 
proteins  [18].  Bax  is  a  key  effector  of  mitochondria-mediated  apoptosis,  and  its  activity  is 
conformationally regulated based on the ratio of BH3-only proteins, such as Bim, to the anti-apoptotic 
Bcl-2 family members [19,20]. Pro-survival Bcl-2 proteins are oncogenic; therefore, the loss of Bim 
expression and/or function may facilitate resistance to apoptotic stress during tumor development. 
Cells rely on cell-cell and cell-matrix interactions for proper differentiation and survival [21,22]. 
Cells  that  lose  these  interactions  die  from  programmed  cell  death  through  a  process  known  as 
“anoikis” [23]. Anoikis relies heavily on the mitochondrial pathway of apoptosis in which Bim is a 
critical  player  that  tips  the  balance  of  detached  cells  towards  enhanced  apoptotic  potential.  Bim 
transcription is found to be upregulated by sevenfold at 24 h after cell detachment. Knockdown of Bim 
renders  NIH3T3,  A549  and  MCF10A  cells  able  to  survive  anoikis  [24–26].  Pokemon  is  a 
transcriptional suppressor of Bim [3]. Aberrantly over-expressed Pokemon may block apoptosis via 
suppression  of  detachment-induced  Bim  upregulation  and  thus  render  cells  able  to  resist  anoikis. 
Resistance to anoikis may allow cancer cells to survive during systemic circulation, thereby facilitating 
secondary tumor formation in distant organs [27,28]. Thus, the acquisition of anoikis resistance is Int. J. Mol. Sci. 2012, 13  5820 
 
 
essential for tumor cell invasion and metastasis. In this report, we studied the role of Pokemon in 
anoikis and identified a Pokemon-Bim-anoikis pathway. 
2. Results and Discussion 
2.1. Pokemon-Silencing Sensitizes Human Hepatoma to Anoikis and an Apoptosis Inducer 
We  examined  the  expression  of  the  Pokemon  protein  in  three  human  hepatoma  and  two  
non-malignant liver cell lines. QGY7703, HepG2 and Bel7704 human hepatoma cells and QSG7701 
and HL7702 human liver cells were studied. Pokemon expression is relatively higher in the three 
human  hepatoma  cells  than  in  the  two  normal  liver  cell  lines,  particularly  in  human  hepatoma 
QGY7703 cells compared to non-malignant liver HL7702 cells (Figure 1a). 
Figure 1. Pokemon expression level. (a) Pokemon protein in normal and cancer liver cells; 
(b) Dose-dependent siRNA silencing of Pokemon in QGY7703 cells. 
 
Silencing was optimized for the down regulation of Pokemon expression in QGY7703 cells using 
si-P1 which has been reported to effectively silence Pokemon in previous study [29]. Figure 1b shows 
the dose-dependent change in Pokemon expression after 48h si-P1 treatment. Figure 2a shows the 
time-dependent  change  in  Pokemon  expression  with  150  pmol  of  si-P1.  The  data  indicated  that 
maximal Pokemon knockdown occurred at 48 h. 
Pokemon is an important proto-oncogene; therefore, we are interested in the effect of Pokemon 
knockdown on QGY7703 liver cancer cells. We analyzed cell proliferation, cell cycle progression and 
apoptosis of QGY7703 cells when Pokemon is silenced. The results showed that Pokemon silencing 
led to a limited decrease in the cell growth rate (Figure 2b), a negligible cell cycle arrest at the G2/M 
checkpoint (Figure 2c), and a slight increase in apoptosis (Figure 2d) during regular culture. These 
changes were marginal with no statistical significance, indicating that under normal cultural conditions, 
Pokemon silencing does not significantly influence cell growth and survival. Furthermore, we tested 
the effect of Pokemon on the cellular response to diverse apoptotic stressors. Doxorubicin treatment 
(Aladdin, China) and detached culture conditions, which induces anoikis, were tested. The results 
showed  that  the  0.5  μM  Doxorubicin  treatment  for  24  h  triggered  approximately  24.55%  of  the 
QGY7703 cells to undergo apoptosis when Pokemon is silenced, whereas 16.38% of cells treated with 
a scrambled siRNA were apoptotic (Figure 2e). Notably, under detached culture conditions, 42.6% of 
Pokemon-silenced  QGY7703  cells  underwent  apoptosis  compared  to  35%  of  cells  treated  with  a 
scrambled siRNA control (Figure 2f). The occurrence of anoikis was confirmed by determination of 
cleaved caspase-3 protein levels in Figure 3b. Int. J. Mol. Sci. 2012, 13  5821 
 
 
Figure  2.  Sensitivity  of  QGY7703  cells  to  anoikis  and  Doxorubicin  under  Pokemon 
knockdown conditions. (a) Time course of Pokemon silencing by small interfering RNAs 
(siRNA) (150 pmol) in QGY7703 cells; (b) Cell growth rate; (c) FASC cell cycle analysis 
of QGY7703 cells treated with 150 pmol siRNA for 48 h after transfection; (d) FASC 
apoptosis analysis of QGY7703 cells treated with 150 pmol siRNA for 48 h; (e) FASC 
apoptosis analysis of QGY7703 cells treated with 150 pmol siRNA for 48 h, followed by 0.5 
μM Doxorubicin treatment; (f) QGY7703 cells were treated with 150 pmol siRNA for 48 h 
and  re-seeded  on  Ultra-Low  attachment  plates.  After  incubation  for  24  h,  cells  were 
processed by FASC apoptosis analysis. 
 
2.2. Pokemon Enhances Resistance of HL7702 Cells to Anoikis 
To further confirm the role of Pokemon in anoikis, we ectopically expressed it in human liver 
HL7702 cells, which have low endogenous expression of Pokemon. Figure 3a shows the Pokemon 
protein levels of HL7702 cells transfected with p3.1 or p3.1-Pok. As shown in Figure 3a, 44.2% of 
HL7702  cells  that  express  Pokemon  exogenously  underwent  apoptosis  compared  to  54.9%  of  the 
vector control cells when cultured under detachment conditions. This protective effect can also be 
detected in stable cell line HL-P and siRNA treated HL-P, as indicated by cleaved caspase-3 (Figure 3c). 
The effect of Pokemon on anoikis was further confirmed by a cell counting study. In this study, 
green fluorescent protein (GFP)-tagged Pokemon was introduced into HL7702 cells. Following culture 
in detached, semi-detached or attached conditions for 48 h, viable fluorescent cells were counted using 
a fluorescent microscope. As shown in Figure 3d, the proportion of GFP-Pokemon-labeled cells was 
elevated by anoikis selection. These changes were not observed in vector control HL7702 cells. The 
results suggest that ectopic GFP-Pokemon expression protects HL7702 cells from anoikis. Int. J. Mol. Sci. 2012, 13  5822 
 
 
Figure 3. Anoikis resistance induced by ectopic expression of Pokemon in HL7702 cells. 
(a) HL7702 cells were treated with p3.1-Pok or p3.1 for 24 h, digested and re-plated on 
ultra-low attachment plates. After a 24 h incubation period, cells were processed by FASC 
apoptosis  analysis.  (b)  Caspase-3  expression  analysis.  HL7702  cells  were  treated  with 
pGFP or pGFP-Pok for 24 h and then treated as described above. QGY7703 cells were 
treated with 150 pmol siRNA for 48 h and then treated as described above. (c) HL-P, HL-G, 
and HL-P cells were treated with 150 pmol siRNA and then treated as described above.  
(d) HL7702 cells transfected with pGFP or pGFP-Pok were re-plated as described in the 
Materials and Methods. 48 h after re-seeding, the ratio of cells with GFP labeling to the 
total number of cells was calculated. The proportion of GFP alone or GFP-Pokemon cells 
subjected to regular, suspension or semi-suspension culture. * p < 0.01. 
 
2.3. Pokemon Prevents Anoikis through Suppression of Bim Expression  
Bim is an apoptotic protein that plays a significant role in anoikis [23], and the Pokemon-Bim 
pathway  was  reported  in  2009  [3].  To  understand  the  mechanism  by  which  Pokemon  suppresses 
anoikis,  we  further  evaluated  the  effect  of  Pokemon  on  Bim  expression.  In  attachment  culture, 
Pokemon silencing did not appear to significantly alter Bim protein levels, although there was a clear 
increase in its mRNA levels (Figure 4a,b). Interestingly, in anoikis induced by detachment, Pokemon 
silencing significantly up-regulated Bim protein levels in QGY7703 cells, and in contrast, ectopic 
Pokemon expression significantly reduced Bim protein levels induced by  anoikis in HL7702 cells 
(Figure 4c middle). We also detected Bim protein levels in HL-P cells that stably express Pokemon. 
The results showed that stably expressed Pokemon impaired detachment-induced Bim accumulation Int. J. Mol. Sci. 2012, 13  5823 
 
 
and anoikis and that this effect was reversed by siRNA knockdown of Pokemon (Figure 4c). Figure 5d 
shows  that  Matrigel  weakened  Bim  accumulation.  As  in  previous  studies,  the  failure  of  Bim  to 
accumulate corresponds with a failure to proceed with anoikis [24,25]. This finding also explains how 
Matrigel reverses the selective effect of anoikis in the fluorescence microscopy assay in which cells 
encounter less apoptosis stress in the presence of Matrigel; therefore, the survival advantage brought 
about by exogenous Pokemon would not be achieved. These results suggest that Pokemon regulates 
anoikis through suppression of Bim expression in QGY7703 and HL7702 cells. 
Figure  4.  Pokemon  suppresses  detachment-induced  Bim  upregulation.  (a)  and  (b) 
QGY7703  cells  were  treated  with  150  pmol  siRNA  for  48  h  and  analyzed  by  a  Bim 
Western  blot  or  real-time  RT-PCR;  (c)  QGY7703,  HL-P,  HL-G,  and  HL-P  cells  were 
treated with 150 pmol siRNA or scrambled RNA for 48 h and re-plated onto Ultra-Low 
attachment plates. After incubation for 24 h, Bim expression was assessed by Western blot. 
HL7702  cells  were  transfected  with  pGFP  or  pGFP-Pok.  24  h  after  transfection,  Bim 
expression was analyzed as described above. 
 
To rule out the possibility of off-target effect, anoikis induced Bim accumulation was assessed 
using other si-RNAs. As shown in Figure 5a, si-P2 effectively silenced Pokemon and the time-course 
result was consistent with former ones (Figure 5b). Figure 5c shows that silencing of Pokemon by  
si-P2 also enhanced Bim accumulation under detachment. Thus, the increased Bim accumulation under 
detachment when Pokemon is silenced is not caused by off-target effects. Int. J. Mol. Sci. 2012, 13  5824 
 
 
Figure 5. Pokemon silenced by si-P2. (a) Pokemon expression level of QGY7703 treated 
with scramble RNA , Si-P1, Si-P2, Si-P3 and scramle RNA; (b) Pokemon expression level 
of QGY7703 treated with Si-P2 for 48 h, 72hr and 96 h; (c)  Bim expression level of 
QGY7703 after si-P2 treatment; (d) Bim expression level of HL7702 under suspension or 
semi-suspension culture. 
 
2.4. Pokemon Suppresses Bim Expression via Direct Binding to the Bim Promoter 
We further investigated the regulatory mechanism by which Pokemon, which is a transcription 
factor [3], affects Bim expression. Figure 4a shows that Pokemon silencing increased Bim mRNA 
levels,  but  Bim  protein  level  was  not  significantly  changed  (Figure  4b).  It  seems  that  Pokemon 
silencing enhances Bim transcription, but the extra Bim protein is degradated so that the balance of 
Bcl-2 protein is maintained in cells. The resultsindicate that Pokemon may regulate Bim expression at 
the promoter level without influencing Bim degradation Data from a dual luciferase reporter assay 
confirmed the presence  of a regulatory activity  of Pokemon  on the  Bim  promoter  whose  activity 
decreases along with Pokemon expression increasing (Figure 6a). A ChIP assay showed that Pokemon 
binds to the Bim promoter in both HepG2 and QGY7703 cells (Figure 6b). These data suggest that 
Pokemon suppresses Bim expression via direct binding to the Bim promoter. Int. J. Mol. Sci. 2012, 13  5825 
 
 
Figure  6.  Pokemon  suppresses  Bim  expression  by  directly  binding  to  its  promoter.  
(a) HL7702 cells were treated as indicated in the Materials and Methods. Forty-eight hour 
after transfection, the cells were processed by the dual luciferase reporter assay. p-POK is 
abbreviation for p3.1-POK. The doses of p-POK for each bar are 0, 0, 0, 0.1 μg, 0.2 μg,  
0.4 μg, 0.8 μg from left to right. (b) Images showing ChIP PCR results from HepG2 (upper 
panel) and QGY7703 (lower panel) cells. 
 
2.5. Discussion 
Liver cancer is the most prevalent and most lethal cancer worldwide, especially in Asia, where the 
incidence and mortality are strikingly high [30]. Pokemon has been reported to be highly expressed in 
some cancers, including hepatoma, and particularly in metastasized hepatoma [4]. These reports imply 
that there is a potential role for Pokemon in the development, progression, and especially metastatic 
transformation  of  hepatoma.  This  study  revealed  that  Pokemon  suppresses  anoikis  by  inhibiting 
expression of the apoptotic protein Bim, thereby advancing the understanding of the pathological role 
of Pokemon in hepatoma. 
The effect of Pokemon on cell growth and survival was marginal under normal culture conditions. 
Pokemon is a negative transcription factor that represses the tumor suppressor genes p53, p21 and Rb 
as  well  as  the  Bcl-2  family  pro-apoptotic  protein  Bim  [7,13].  All  of  these  genes  function  in  a 
homeostatic  way  under  normal  culture  conditions  but  are  induced  or  activated  under  certain 
circumstances,  which lead to  relevant  biological  consequences.  Therefore, it is  not  surprising that 
Pokemon silencing did not have striking effects on cell growth and survival as shown by our results. 
A question we asked in this study was whether Pokemon confers a survival advantage to cells in 
harsh  environments,  such  as  in  the  presence  of  chemical  reagents  and  during  cell  detachment. 
Therefore, we tested the effect of Pokemon expression on QGY7703 cells exposed to a chemical 
inducer or cultured under detachment conditions. Either transient or stable expression or silencing of 
Pokemon affects the cell’s sensitivity not only to apoptosis triggered by a chemical inducer but also 
dramatically to anoikis. Solid evidence was also obtained in a fluorescence microscopy study. In this 
assay,  the  dramatically  increased  proportion  of  green  cells  after  anoikis-selection  and  the 
correspondingly opposing effect of Matrigel supplements suggest a survival advantage for cells with Int. J. Mol. Sci. 2012, 13  5826 
 
 
increased Pokemon expression due to anoikis. These data suggest that Pokemon improves the ability of 
liver  cancer  cells  to  survive  harsh  environments  caused  by  chemical  reagent  or  detachment.  This 
protective effect, which is essential for cells to survive in the presence of increased apoptotic stress, as 
is the case during the process of erythroid development, is exploited in tumor cells, as Pokemon allows 
QGY7703 cells to survive not only a higher concentration of Doxorubicin but also suspension culture. 
As a supplement to a previous study showing that Pokemon plays an important role in tumorigenesis, 
our study shows that Pokemon may also promote tumor cell invasion and metastasis by improving the 
ability of tumor cells to avoid anoikis because anoikis is a key barrier to metastasis for tumor cells. 
Anoikis relies heavily on Bcl-2 family protein-mediated apoptosis. Bim is a key regulator of anoikis, 
and  changes  in  Bim  are  sufficient  to  influence  cell  anoikis  [19,26].  Our  study  showed  that  the 
Pokemon-Bim regulation pathway that  exists  in mice erythroid  development also  functions  in the 
process  of anoikis.  Under regular culture conditions,  Pokemon  silencing  in  QGY7703 cells  had a 
limited  effect  on  Bim  protein  levels,  although  its  mRNA  levels  were  increased.  However,  under 
detachment stress, Pokemon greatly changed Bim protein expression. In the cell lines we studied, 
increased  Pokemon  levels  were  correlated  with  decreased  Bim  accumulation.  Studies  of  the  Bim 
promoter using luciferase reporter and ChIP assays further revealed that Pokemon regulates anoikis in 
liver cells by controlling Bim expression via direct binding to the Bim promoter. We proposed a 
hypothetical pathway in which Pokemon regulates anoikis. When cells with low Pokemon levels are 
exposed to detachment  conditions, Bim transcription is upregulated and Bim protein accumulates; 
therefore, the cells undergo apoptosis. When Pokemon is overexpressed in cells, Bim transcription is 
blocked, which leads  to  a failure to  accumulate Bim protein, causing an impairment  of apoptosis 
induced by detachment. It is noteworthy that under normal culture conditions (non-anoikis), Pokemon 
silencing enhanced the mRNA but not the protein levels of Bim, which indicates the possibility that a 
translational regulatory mechanism exists. Further study is warranted to test this hypothesis. 
3. Experimental Section 
3.1. Cell Lines and Culture 
Human hepatoma (QGY7703, HepG2, and BEL7404) and non-malignant QSG7701 and HL7702 
liver  cell  lines  were  purchased  from  the  Shanghai  Institutes  of  Biological  Sciences  Cell  Bank 
(Shanghai,  China).  QGY7703  and  HepG2  cells  were  maintained  in  Dulbecco’s  Modified  Eagle 
medium (DMEM) containing 10% fetal bovine serum (FBS) at 37 ° C, 5% CO2. QSG7701, BEL7404 
and HL7702 cells were maintained in RPMI 1640 medium with 10% FBS. Stable cell lines were 
established  as  previously  described  [31].  Briefly,  HL7702  cells  were  transfected  with  the 
corresponding plasmids. After 48 h, the cells were trypsinized, diluted, and re-seeded onto plates, 
followed  by  G418  selection  for  stable  transfectants.  For  detachment  culture,  cells  were  seeded  in  
Ultra-Low attachment 6-well plates (Corning, Glendale, Arizona, USA), and 1% methylcellulose was 
added to full media to avoid the survival effect caused by cell clumping. Int. J. Mol. Sci. 2012, 13  5827 
 
 
3.2. Plasmid Construction 
PCR-amplified Pokemon cDNA was cloned into the pcDNA3.1(−) and pEGFP-N3 vectors, and the 
resulting constructs were named p3.1-POK and pGFP-POK, respectively [32]. The Bim promoter was 
cloned into the pGL4.10 vector and named p4.10-bim800. All vectors were constructed according to 
standard cloning procedures. The primers used for the Bim promoter were Bim-p forward: 5′-ATA 
GGT ACC ATG CCT CCC GCC CTC ACC CGG GA-3′, and Bim-p reverse: 5′-TTA CTC GAG TTG 
AGC TCC AAC AAA CTG CAG ACC-3′. 
3.3. Pokemon Silencing by siRNA 
Three siRNAs were synthesised and were used to target Pokemon as described in previous studies [31]. 
The sequences are as follows: si-P1 sense 5′-GCU GGA CCU UGU AGA UCA Att-3′, si-P2 sense  
5′-UCA AGA AAG ACG GCU GCA Att-3′ and si-P3 sense5′-GCA GAU GAU GUC AUC GGU Gtt-3′. 
For  siRNA  delivery,  cells  (2  ×   105  in  Opti-MEM  I  media)  were  mixed  gently  with  siRNA  and 
OligofectAMINE  (Invitrogen,  Grand  Island,  New  York,  USA)  in  a  final  volume  of  0.5–1.5  mL, 
according the manufacturer’s instructions, and incubated at 37 ° C, 5% CO2 for 4 h, followed by the 
addition of an equal volume of fresh media containing 20% FBS. Cells were continuously incubated 
until harvest. 
3.4. Flow Cytometry Analysis 
For  apoptosis  analyses,  cells  were  harvested  and  stained  using  an  Annexin  V-FITC  apoptosis 
analysis kit (Beyotime, China) according to the manufacturer’s instructions. For cell cycle analyses, 
the cells were trypsinized, washed with PBS twice, and fixed with ethanol (−20 ° C). Before flow 
cytometry analyses, the ethanol was removed, and 1 mL of freshly made dying solution (0.05 mg/mL 
PI, 0.025 mg/mL RNase, 0.0025% TritonX-100) was added. After staining for 5 min, the cells were 
subjected to flow cytometry analysis, using a MoFloTM XDP cytometer (Beckman Coulter, Atlanta, 
Georgia, USA). Three replicates were performed. 
3.5. Real-Time PCR 
Total RNA was extracted using the Trizol reagent (Invitrogen, Grand Island, New York, USA) 
according  to  the  manufacturer’s  instructions  and  quantified  with  a  Nano-drop  ND-1000  (Thermo 
Scientific,  Wilmington,  Delaware,  USA).  The  quality  of  the  RNA  was  verified  by  agarose-gel 
electrophoresis. Real-time PCR was performed on an AB 7500 Real Time PCR System using the 
cDNA obtained above. The results were analyzed by the AB 7500 PCR system SDS software (Applied 
Biosystems, Bedford, Ohio, USA). Three replicates were performed. 
3.6. Western Blot 
Lysates (30 μg protein) of treated or non-treated cells were resolved by SDS-PAGE, transferred to 
PVDF membranes, and blocked with 0.5% skim milk in 1×  TBS. Membranes were incubated with 
primary antibodies overnight at −4 ° C and washed three times for 10 min each in TBST (20 mM  Int. J. Mol. Sci. 2012, 13  5828 
 
 
Tris-HCl,  pH  7.5,  150  mM  NaCl,  0.05%  Tween-20).  The  membranes  were  then  incubated  with  
HRP-conjugated secondary antibodies for 1.5 h at room temperature. Images were acquired using the 
GeL Doc EQ image reader system (Bio-Rad, Munich, Germany). Protein amounts were normalized 
according  to  beta-actin  monoclonal  antibody  staining.  The  antibodies  used  included  anti-human 
Pokemon (Sigma, USA), anti-human BIM, anti-caspase3 and anti-cleaved caspase-3 (Cell Signaling 
Technology, Danvers, Massachusetts, USA), and anti-human beta-actin (Beyotime, DaLian, China). 
3.7. Chromatin Immunoprecipitation 
Subconfluent QGY7703 or HepG2 cells were fixed with 1% formaldehyde, washed with PBS, lysed 
with  SDS  lysis  buffer  (50  mM  Tris-HCl,  pH  8.1,  5  mM  EDTA,  0.1%  deoxycholate,  1%  Triton  
X-100,150 mM NaCl, 1% protease inhibitor cocktail), and sonicated to generate DNA fragments of 
500–1000 bp in size. Pre-immune serum was added to the sonicated supernatant and incubated for 1 h 
at 4 ° C with rotation. Protein G Dynabeads (Invitrogen, USA） were added and incubated for 1 h at 4 ° C. 
A magnetic separator was used to collect the beads. The supernatant was diluted 2-fold with ChIP 
dilution buffer (0.01% SDS, 1% Triton X-100, 2 mM Tris-HCl, pH 8.1, and 150 mM NaCl) and 
incubated  with  either  anti-Pokemon  antibody  or  IgG  as  a  control  at  4  ° C  overnight.  Protein  G 
Dynabeads were added to the mixture, incubated for 2 h at 4 ° C with rotation, and separated with the 
magnetic separator. DNA-Pokemon-antibody complex was eluted with TE buffer at pH 3.0. After 
EDTA and proteinase K treatment, DNA was extracted with phenol/chloroform and precipitated with 
ethanol.  The  primers  used  were  Bim1-forward:  5′-TCG  CGA  GGA  CCA  ACC  CAG  TC-3′  and  
Bim1-reverse: 5′-CCG CTC CTA CGC CCA ATC AC-3′. 
3.8. Dual Luciferase Reporter Assay 
A dual luciferase reporter assay system was purchased from Promega, USA and used according to 
the manufacturer’s instructions. Briefly, HL7702 cells were cultured in RPMI 1640 medium with 10% 
FBS on 6-well plate and were transfected with 0.8 μg of pRL-TK , 0.8 μg of pGL-4.10 or pBim-800 
and 0.8μg of pcDNA3.1 and p3.1-POK using FuGENE HD (Roche, USA). After 36 h of incubation, 
cells were harvested, lysed, and 10 μL of the resulting lysate was used to test luciferase activity. 
Different Pokemon expression levels are obtained by transfecting different dose of p3.1-POK. 
3.9. Cell Counting Assay 
HL7702 cells were transfected with pGFP-POK or control vector for 24 h, trypsinized and divided 
into three equal parts, labeled I, II and III. Part I was re-seeded onto regular six-well plates. Parts II and 
III were plated on Ultra-Low attachment 6-well plates. Five percent matrigel was added to plates 
containing Part II cells. After 48 h, green fluorescent cells were counted in five random areas of view 
using a fluorescence microscope (Olympus, Japan). Three replicates were performed. 
4. Conclusions 
Pokemon render liver cells better ability to resist anoikis by suppressing Bim accumulation via direct 
bind to Bim promoter. The Pokemon-Bim pathway is essential in mice erythroid development [3], but Int. J. Mol. Sci. 2012, 13  5829 
 
 
these new research findings reveal a novel function of this pathway in tumor progression, providing 
experimental support for the potential role of Pokemon in tumor metastasis. Pokemon-targeted cancer 
therapy may effectively suppress not only carcinoma in situ but also tumor metastasis and replacement. 
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